We’re leaving off late legends like Audrey Hepburn, focusing more on actors from recent memory. Which of these actors would ...

Whether it was the mystery of the hatch, the Man in Black or a flash sideways, few shows have ever kept viewers guessing ...

Indianapolis: Eli Lilly and Company and EVA Pharma have announced that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in 49 low- to ...

Shares of Eli Lilly (LLY) hit resistance and reverse. Successful traders understand the market dynamics that make this happen. When stocks rally, they tend to run into resistance if they reach a ...

Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 low to middle-income African countries by 2030. Baricitinib is a Janus kinase (JAK) inhibitor ...

Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases across 49 low- to middle-income countries in ...

The agreement is part of Lilly’s 30×30 strategy. Credit: rafa press/Shutterstock. Eli Lilly and EVA Pharma have formed a partnership to increase the availability of baricitinib in 49 low to ...

INDIANAPOLIS and CAIRO - Eli Lilly and Company (NYSE: NYSE:LLY) and EVA Pharma have entered into a new agreement to increase the availability of the immunological treatment baricitinib in 49 African ...

Sept 4 (Reuters) - Eli Lilly (LLY.N), opens new tab will license the manufacturing know-how for its rheumatoid arthritis treatment to Egypt's Eva Pharma, the companies said on Wednesday ...